Paulo Gaspar keeps buying Scandi Standard as poultry stays firm

Scandi Standard does not make a commodity chicken story. It makes branded, processed poultry for the Nordic and Irish markets, which is a different business from simply shipping raw bird into a wholesale channel and hoping the spread behaves. That matters because the stock tends to move on a mix of volume, feed costs, retail pricing, and how well the company can push more value-added product through its plants. When those pieces line up, the market usually notices before the next quarterly report does.

The broader European backdrop still helps. EU chicken meat production is forecast to rise more than 2% in 2027 after 3.4% growth in 2026, according to the USDA-backed outlook cited in the research. Domestic consumption remains steady, Brazilian imports were banned from September 3, 2026, and avian influenza cases have been at seasonal lows across Europe. Spain and Poland are both positioned for expansion on positive margins and export opportunities. That is the sort of backdrop that can keep a poultry name from being treated like a dead-end defensive.

The stock itself had already done a lot of the work. It closed at SEK 169.40 on September 24, down 0.35% on the day, and traded around SEK 171.20 on September 25, up about 1%. Year to date, it was up roughly 70% to 72% around those filings. So this is not a sleepy board member buying after a collapse. This is a buyer leaning in after a strong run, which is a different read entirely.

What Paulo Gaspar actually bought

Paulo Gaspar, a board member, kept adding through Scandi Standard via the company’s largest shareholder, Grupo Lusiaves SGPS SA. The most recent verified filings show purchases on September 24 and 25 totaling roughly EUR 436,117.36, EUR 214,440.53 and EUR 112,233.39 in euro-normalised filing value, alongside an earlier September 21 purchase of 14,332 shares at SEK 169.66 per share for approximately SEK 2.4 million. The pattern is not a one-off. It is a series.

That is why the filing matters more than the headline number alone. One buy can be noise, especially in a name that has already rerated. A sequence of buys from the same board-linked party is harder to dismiss because it tells you the buyer did not lose interest after the first clip. Our scoring puts this at 5.6, and the reason is plain enough, the name sits in a wide cluster, the position size is meaningful relative to market value, and the company is in the small to mid-cap band where insider activity has historically been less fully priced in. You do not need to worship the score to see why it lights up here.

The size is not trivial either. The latest EUR 436,117.36 filing value is about 0.04% of the company’s market value in our data. That is not a board member buying lunch money. It is also not a control-shifting event. It sits in the middle ground that often matters most, where the buyer has enough skin in the game to be worth your attention, but not so much that the trade becomes a corporate action in disguise.

A poultry business with a real operating lever

Scandi Standard’s business model gives the market something to work with. It sells chicken products under brands such as Kronfågel and Manor Farm, and it has been pushing through volume growth, margin expansion and integration work. Its Q2 2026 results showed EBIT up 30% year over year, according to the company report cited in the research. That is the kind of number that changes how the market treats a food name. Not because it is glamorous, but because it says the company is getting more out of the same basic protein cycle.

The company is also not standing still on the portfolio side. It has been advancing acquisitions and efficiency programs, and the Glenhaven Foods deal is the latest example. Competition clearance came through on September 22, with completion expected around October 9. Management said the acquisition meets operational and financial criteria, adds more than 10% to pro forma 2025 EPS after dilution and financing, and gives the group a bridgehead into the UK retail market. That is a concrete strategic move, not a vague synergy slide.

The analyst side is not fighting the story either. SB1 Markets reiterated a buy rating on September 25 and raised its price target to SEK 190 from SEK 180, pointing to expected earnings growth from the Ready-to-Eat segment, Lithuania operations and Glenhaven, while treating higher feed costs as temporary. You do not have to agree with the target to see the shape of the debate. The market is weighing whether Scandi Standard can keep turning a favorable protein backdrop into earnings growth rather than just margin relief.

The cluster is the context, not the headline

InsiderTrades data shows this as a cluster, with 8 insiders trading the name in the same direction over the past quarter and 12 recent declarations in the dossier. That is useful because it tells you the September buying was not isolated to one board member waking up bullish on a Tuesday. It sits inside a broader pattern of accumulation. The recent declarations in the dossier include Paulo Gaspar on September 22, 24 and 25, plus Pia Gideon on September 23. That is enough to say the board-level tone has been constructive.

Still, clusters can be overread. A cluster does not tell you whether the next quarter will be clean, whether feed costs will behave, or whether the market has already priced in the good news. It tells you that several insiders, in the same direction, have chosen this moment to add exposure. In a company that has already rallied hard, that is a useful clue, but it is not a verdict.

The historical cohort data gives you a second lens. For the bucket labeled ca/board buys at sweet-spot names, with a sample size of 2,197, the T+90 win rate is 53.7% and the average return is 2.18%. The 365-day average return is 72.79%. That is historical cohort data for a role-and-size bucket, not a forecast for Scandi Standard and not a promise that this trade will work. It does, however, tell you that this type of filing has not been random noise in our dataset.

Why the stock has already earned a harder look

The stock’s year-to-date move changes the burden of proof. When a name is up roughly 70% to 72% before the latest buys, you are no longer asking whether the market has noticed. It has. You are asking whether the next leg can come from earnings, integration, and product mix rather than just rerating. That is where Scandi Standard becomes more interesting than a simple insider-buy story.

The Swedish market backdrop has also been constructive. The OMXS30 closed at 3,295.03 on September 25, up 0.73% that day and roughly 25.6% year to date. Scandi Standard has outperformed that broad index by a wide margin, which means the stock is already carrying expectations. In that setting, insider buying can still matter, but it matters as confirmation of internal confidence, not as a cheap entry point signal.

The business itself has a few moving parts that can support further earnings work. Ready-to-eat is one. Lithuania is another. Glenhaven adds a UK retail bridgehead. Feed costs remain the obvious swing factor, and the analyst note in the research treats that as temporary rather than structural. If that view holds, the company has a path to keep converting sector tailwinds into reported profit. If it does not, the stock will not get much mercy from a market that has already paid up.

Where the filing fits the mechanism

The mechanism here is straightforward. Chicken demand in Europe is still supported by consumer preference, relative affordability, and a lower-carbon profile versus some other proteins. Scandi Standard sits in the part of the market where branding, processing, and distribution matter, so it can capture more than just raw commodity spread. Then you add acquisitions, efficiency work, and a board that keeps buying through the largest shareholder. That is the chain.

The insider filing fits at the end of that chain, not the beginning. It does not create the demand backdrop. It does not fix feed costs. It does not close Glenhaven. What it does is tell you that a board-linked buyer is willing to add exposure after a strong run and during a period when the company is still executing. That is the kind of behavior you want to see if you are trying to separate a rerating that has run too far from one that still has operating support.

InsiderTrades data also puts the name in a small or mid-cap band where insider information has historically been least priced in. That does not mean the market is blind. It means the filing can still carry incremental value because the stock is not one of those mega-cap names where every board trade gets buried under passive flows and index noise. In a name like this, the filing can still move the discussion.

What can break the story from here

The obvious risk is that the stock has already done a lot. A 70% plus year-to-date move leaves less room for disappointment. If feed costs turn less temporary than SB1 Markets expects, or if integration work takes longer than management wants, the market will not pay for the same story twice. That is especially true after a run where the company has already benefited from a successful rights issue and acquisition financing, according to the research.

There is also the valuation problem that comes with momentum. Once a stock has rerated, good news stops being enough. It has to be better than expected. Glenhaven needs to land cleanly. Ready-to-eat needs to keep contributing. Lithuania needs to keep doing its part. And the broader poultry backdrop, while supportive, is still exposed to disease headlines, feed inputs and consumer pricing. Seasonal lows in avian influenza are helpful, but they are not a permanent shield.

The internal fundamentals screen is decent, not pristine. InsiderTrades data shows a fundamental score of 51, with a value score of 46 and a quality score of 55. That is a workable profile, not a screaming bargain and not a broken balance sheet story. It fits a company that can execute, but it does not remove the need to watch the next operating print carefully.

The next print matters more than the filing

The filing gives you a reason to keep Scandi Standard on the page. The next report tells you whether the market has been right to keep rewarding it. If the company can keep showing volume growth, margin expansion and clean integration, the insider buying will look like a board member leaning into a business that still has room to run. If the next quarter shows the usual food-sector friction, the same buys will look more like confidence at the top of the range.

For now, the useful read is simple. Scandi Standard is not just riding a poultry tailwind. It is using that tailwind to push through earnings growth, acquisitions and a more valuable product mix, and a board-linked buyer has kept adding while the stock is already up sharply. That combination is why the filing deserves attention, even if you keep your expectations disciplined and your position sizing smaller than the headline enthusiasm would suggest.

This is not investment advice.